Therese Takas

Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants

M. Pamela Griffin, Yuan Yuan, Therese Takas et al. · New England Journal of Medicine · 2020 · 747 citations · Full text

Medicine, Infectious Diseases, Pediatrics +13

Efficacy of nirsevimab against respiratory syncytial virus lower respiratory tract infections in preterm and term infants, and pharmacokinetic extrapolation to infants with congenital heart disease and chronic lung disease: a pooled analysis of randomised controlled trials

Eric A. F. Simões, Shabir A. Madhi, William J. Muller et al. · The Lancet Child & Adolescent Health · 2023 · 318 citations · Full text

Medicine, Infectious Diseases, Pediatrics +15

Safety, Tolerability and Pharmacokinetics of MEDI8897, an Extended Half-life Single-dose Respiratory Syncytial Virus Prefusion F-targeting Monoclonal Antibody Administered as a Single Dose to Healthy Preterm Infants

Joseph B. Domachowske, Anis A. Khan, Mark T. Esser et al. · The Pediatric Infectious Disease Journal · 2018 · 231 citations · Full text

Pharmacy, Pediatrics, Pharmacokinetics +17

Safety, Tolerability, and Pharmacokinetics of MEDI8897, the Respiratory Syncytial Virus Prefusion F-Targeting Monoclonal Antibody with an Extended Half-Life, in Healthy Adults

M. Pamela Griffin, Anis A. Khan, Mark T. Esser et al. · Antimicrobial Agents and Chemotherapy · 2016 · 146 citations · Full text

Veterinary Medicine, Infectious Diseases, Pediatrics +15

An Adjuvanted, Postfusion F Protein–Based Vaccine Did Not Prevent Respiratory Syncytial Virus Illness in Older Adults

Judith Falloon, Jing Yu, Mark T. Esser et al. · The Journal of Infectious Diseases · 2017 · 133 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17